Inventor · disambiguated record
John Soong
Also filed as: SOONG JOHN
5 granted patents·6 pending applications·2 citations·filing 2010–2021
66Inventor score
Top patents by PatentIndex Score
11 records- 0181US10857156B2Combination therapy of tetracyclic quinolone analogs for treating cancerSENHWA BIOSCIENCES INC·Filed 2016·Granted Dec 8, 2020·2 cites·12 claims
- 0268US2022088029A1Combination therapy of tetracyclic quinolone analogs for treating cancerSENHWA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0367US11524012B1Quinolone analogs and their salts, compositions, and method for their useSENHWA BIOSCIENCES INC·Filed 2021·Granted Dec 13, 2022·0 cites·26 claims
- 0467US11229654B2Combination therapy of tetracyclic quinolone analogs for treating cancerSENHWA BIOSCIENCES INC·Filed 2019·Granted Jan 25, 2022·0 cites·13 claims
- 0562US2021113584A1Combination therapy of tetracyclic quinolone analogs for treating cancerSENHWA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 0660US12116363B2Combinations for immune-modulation in cancer treatmentSENHWA BIOSCIENCES INC·Filed 2019·Granted Oct 15, 2024·0 cites·14 claims
- 0753US2022062294A1Pharmaceutical compositions of tetracyclic quinolone analogs and their saltsSENHWA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0848US2019374550A1Quinolone analogs and their salts, compositions, and method for their useSENHWA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 0946US2021046071A1Tetracyclic compounds and their salts, compositions, and methods for their useSENHWA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1036US8741882B2Anti-diabetic compoundsSOONG JOHN·Filed 2012·Granted Jun 3, 2014·0 cites·11 claims
- 1131US2012058961A1Pharmaceutical Composition for Treating CancersSOONG JOHN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Soong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →